Petra Pharma Funding: $48M Raised, Series A (2015)
Petra Pharma is based in New York, NY. It has raised $48M in total funding. Latest round: Series A.
Petra Pharma funding overview
Petra Pharma is based in New York, NY. Petra Pharma has raised $48M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2015. The round record for Petra Pharma runs through 2015; nothing later has been disclosed. Investors on record include AbbVie, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, 180 Degree Capital Corp., Empire State Development's Innovate NY Fund and 5 others. 11 distinct backers are named across the disclosed rounds.
Petra Pharma at a glance
Total raised
$48M
Latest round
Series A
Latest round date
January 2015
Headquarters
New York, NY
Notable investors
AbbVie, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, 180 Degree Capital Corp., Empire State Development's Innovate NY Fund, Johnson & Johnson Innovation - JJDC, Inc., Partnership Fund for New York City
Frequently asked about Petra Pharma funding
How much has Petra Pharma raised?
Petra Pharma has raised $48M in total disclosed funding across the rounds on record.
Who has invested in Petra Pharma?
AbbVie, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, 180 Degree Capital Corp., Empire State Development's Innovate NY Fund are named among the investors backing Petra Pharma.
What was the latest Petra Pharma funding round?
The most recent disclosed round is a Series A, announced in January 2015.
Where is Petra Pharma based?
Petra Pharma is based in New York, NY.
When did Petra Pharma last raise?
The last disclosed Petra Pharma round closed in January 2015 at Series A.
Petra Pharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.
